New CDMO Facility
Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare
Grifols
PAO-02-23-PATV-04Feb 23, 2023
Parenteral Drug Products
Innovating to Optimize Quality in Injectable Drugs
Michael Howell
Grifols
PAO-11-022-CL-16Jan 12, 2023
Alzheimer's Vaccine
Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's
Araclon Biotech
PR-M03-22-06Mar 15, 2022
Parenteral Manufacturing
Staying Ahead of Trends in Small-Volume Parenteral Manufacturing
Marga Viñes; Oriol Prat; Oriol Argemi
Grifols
PAO-01-22-R250-08Jan 28, 2022
Recombinant Proteins
Meeting the Renewed Demand for Microbial Protein Production
Grifols Recombinant Protein CDMO
PAO-01-22-R250-07Jan 28, 2022
Parenteral Drugs
A CDMO Dedicated to Supporting Small-Volume, Small-Molecule Parenteral Projects
Marga Viñes; Oriol Prat; Oriol Argemi
Grifols
PAO-12-21-CL-02Dec 13, 2021
Hyperimmunes
GigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature Biotechnology
Grifols
PR-M04-21-018Apr 19, 2021
Acquisition
Grifols Reinforces its Innovation Strategy After Completing the Acquisition of GigaGen to Boost a Novel Method to Generate a Wide Range of Immunoglobulins
Grifols
PR-M11-20-045Mar 09, 2021
Parenterals
Trends Shaping the Dynamic Market for Parenterals
Marga Viñes
Grifols
PAP-Q3-20-CL-018Sep 29, 2020
Continuous Improvement
The Critical Role of Continuous Improvement in Parenteral Drug Manufacturing
Antonio A. Gomez
Grifols
PAP-Q1-20-CL-010Mar 19, 2020
Orphan Drugs
Customer Engagement and Information Sharing are Essential for Success in Orphan Drug Outsourcing
Marga Viñes
Grifols
PAP-Q3-19-CL-013Oct 29, 2019
FDA Approval
Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies
Grifols
PR-M07-19-NI-018Jul 09, 2019
Parenteral Manufacturing
Catering to a Growing Demand for Small-Volume Parenteral Manufacturing
Oriol Prat
Grifols
PAO-M04-19-CL-001May 28, 2019
Parenteral Solutions
Supporting Small and Emerging Pharma through Collaboration and Specialized Expertise
Marga Viñes
Grifols
PAP-Q2-2019-CL-017May 24, 2019
Form-Fill-Seal
Investing in Form-Fill-Seal Technology
Lluc Mercadé
Grifols
PAP-Q1-2019-CL-011Apr 12, 2019
Facility Opening
Grifols Announces the Opening of its new Plasma Donor Center in Russellville, AR
Grifols
PR-M03-19-NI-082Mar 28, 2019
FDA Approval
Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System
Grifols
PR-M02-19-NI-017Feb 08, 2019
Quality
Continuous Quality is Essential in Parenteral Manufacturing
Marta Serra
Grifols
PAO-M12-18-CL-003Dec 19, 2018
FDA Approval
FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing
Grifols
PR-M10-18-NI-047Oct 15, 2018
Terminal Sterilization
Terminal Sterilization for Parenteral Drugs: Finding the Right CDMO Partner
Lluis Twose
Grifols
PAP-Q3-18-CL-015Oct 02, 2018